Neurological
Cancer

Oncology Solutions

In the United States, about 23,820 malignant tumors of the brain or spinal cord will be diagnosed in 2019.1 With the technological advances in the technology field, brain tumor imaging has become an essential component in managing the patients across the care pathway.

The Patient Journey

  • SIGNA™ Artist - 70cm

    Now the potential for MR is even more astonish...
  • SIGNA™ Architect AIR™ Edition

    SIGNA™ Architect AIR™ Edition, GE Healthcare’s premium 3.0T, 70 cm wide bore MR system, leverages intelligent scanning technology to enable patient-friendly exams with ...

  • MR Radiation Oncology Suite

    Our MR Radiation Oncology Suite provides the tools designed to help you better target and treat tumors through consistent patient positioning.
  • PET VCAR

    Comprehensive PET oncology analysis solution with multi-modality and multi-time metabolic and anatomic evolution comparison.
  • SIGNA™ PET/MR with QuantWorks – 60cm

    Introducing SIGNA™ PET/MR with QuantWorks. Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with ...

The latest in Oncology


1. https://www.cancer.org/cancer/brain-spinal-cord-tumors-adults/about/key-statistics.html

JB04823XX

WIPRO GE HEALTHCARE PVT LTD
No. 4, Kadugodi Industrial Area,
Bangalore 560067,
Karnataka, India
CIN: U33111KA1990PTC01606
Grievance Officer: Nestor J. Rivera
Chief Privacy Counsel/Officer, GE HealthCare